Use of a [14C]microtracer in a first-in-human study for BMS-813160, an inhibitor of chemokine receptors 2 and 5, to facilitate collection of early information on drug disposition and metabolism in humans

被引：0

作者：

Su, Hong ^{[1
]}

Mangus, Heidi ^{[2
]}

Liu, Guowen ^{[2
]}

Caceres-Cortes, Janet ^{[3
]}

Gong, Sharon ^{[4
]}

Allentoff, Alban ^{[4
]}

Schulingkamp, Robert ^{[5
]}

Boulton, David W. ^{[6
]}

Chen, Chunlin ^{[6
]}

Iyer, Ramaswamy A. ^{[1
]}

Humphreys, William G. ^{[1
]}

Christopher, Lisa J. ^{[1
]}

机构：

[1] Bristol Myers Squibb, Biotransformat, Princeton, NJ USA

[2] Bristol Myers Squibb, Bioanalyt Sci, Princeton, NJ USA

[3] Bristol Myers Squibb, Discovery Analyt Sci, Princeton, NJ USA

[4] Bristol Myers Squibb, Radiochem, Princeton, NJ USA

[5] Bristol Myers Squibb, Drug Safety & Evaluat, Princeton, NJ USA

[6] Bristol Myers Squibb, Exploratory Clin & Translat Res, Princeton, NJ USA

来源：

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

P63

引用

页码：57 / 57

页数：1